Salem Investment Counselors’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-130
| Closed | -$4.1K | – | 1172 |
|
|
2023
Q4 | $4.1K | Hold |
130
| – | – | ﹤0.01% | 931 |
|
|
2023
Q3 | $3.32K | Hold |
130
| – | – | ﹤0.01% | 934 |
|
|
2023
Q2 | $3.73K | Buy |
130
+30
| +30% | +$861 | ﹤0.01% | 948 |
|
|
2023
Q1 | $2.4K | Hold |
100
| – | – | ﹤0.01% | 970 |
|
|
2022
Q4 | $1.7K | Hold |
100
| – | – | ﹤0.01% | 966 |
|
|
2022
Q3 | $1K | Hold |
100
| – | – | ﹤0.01% | 979 |
|
|
2022
Q2 | $2K | Hold |
100
| – | – | ﹤0.01% | 962 |
|
|
2022
Q1 | $3K | Hold |
100
| – | – | ﹤0.01% | 884 |
|
|
2021
Q4 | $4K | Hold |
100
| – | – | ﹤0.01% | 943 |
|
|
2021
Q3 | $5K | Hold |
100
| – | – | ﹤0.01% | 835 |
|
|
2021
Q2 | $3K | Hold |
100
| – | – | ﹤0.01% | 811 |
|
|
2021
Q1 | $4K | Buy |
+100
| New | +$4K | ﹤0.01% | 762 |
|